Peripheral versus central extracorporeal membrane oxygenation for postcardiotomy shock: Multicenter registry, systematic review, and meta-analysis.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
11 2020
Historique:
received: 08 05 2019
revised: 04 10 2019
accepted: 04 10 2019
pubmed: 23 12 2019
medline: 24 11 2020
entrez: 23 12 2019
Statut: ppublish

Résumé

We hypothesized that cannulation strategy in venoarterial extracorporeal membrane oxygenation (VA-ECMO) could play a crucial role in the perioperative survival of patients affected by postcardiotomy shock. Between January 2010 and March 2018, 781 adult patients receiving VA-ECMO for postcardiotomy shock at 19 cardiac surgical centers were retrieved from the Postcardiotomy Veno-arterial Extracorporeal Membrane Oxygenation study registry. A parallel systematic review and meta-analysis (PubMed/MEDLINE, Embase, and Cochrane Library) through December 2018 was also accomplished. Central and peripheral VA-ECMO cannulation were performed in 245 (31.4%) and 536 (68.6%) patients, respectively. Main indications for the institution VA-ECMO were failure to wean from cardiopulmonary bypass (38%) and heart failure following cardiopulmonary bypass weaning (48%). The doubly robust analysis after inverse probability treatment weighting by propensity score demonstrated that central VA-ECMO was associated with greater hospital mortality (odds ratio 1.54; 95% confidence interval, 1.09-2.18), reoperation for bleeding/tamponade (odds ratio, 1.96; 95% confidence interval, 1.37-2.81), and transfusion of more than 9 RBC units (odds ratio, 2.42; 95% confidence interval, 1.59-3.67). The systematic review provided a total of 2491 individuals with postcardiotomy shock treated with VA-ECMO. Pooled prevalence of in-hospital/30-day mortality in overall patient population was 66.6% (95% confidence interval, 64.7-68.4%), and pooled unadjusted risk ratio analysis confirmed that patients undergoing peripheral VA-ECMO had a lower in-hospital/30-day mortality than patients undergoing central cannulation (risk ratio, 0.92; 95% confidence interval, 0.87-0.98). Adjustments for important confounders did not alter our results. In patients with postcardiotomy shock treated with VA-ECMO, central cannulation was associated with greater in-hospital mortality than peripheral cannulation.

Sections du résumé

BACKGROUND
We hypothesized that cannulation strategy in venoarterial extracorporeal membrane oxygenation (VA-ECMO) could play a crucial role in the perioperative survival of patients affected by postcardiotomy shock.
METHODS
Between January 2010 and March 2018, 781 adult patients receiving VA-ECMO for postcardiotomy shock at 19 cardiac surgical centers were retrieved from the Postcardiotomy Veno-arterial Extracorporeal Membrane Oxygenation study registry. A parallel systematic review and meta-analysis (PubMed/MEDLINE, Embase, and Cochrane Library) through December 2018 was also accomplished.
RESULTS
Central and peripheral VA-ECMO cannulation were performed in 245 (31.4%) and 536 (68.6%) patients, respectively. Main indications for the institution VA-ECMO were failure to wean from cardiopulmonary bypass (38%) and heart failure following cardiopulmonary bypass weaning (48%). The doubly robust analysis after inverse probability treatment weighting by propensity score demonstrated that central VA-ECMO was associated with greater hospital mortality (odds ratio 1.54; 95% confidence interval, 1.09-2.18), reoperation for bleeding/tamponade (odds ratio, 1.96; 95% confidence interval, 1.37-2.81), and transfusion of more than 9 RBC units (odds ratio, 2.42; 95% confidence interval, 1.59-3.67). The systematic review provided a total of 2491 individuals with postcardiotomy shock treated with VA-ECMO. Pooled prevalence of in-hospital/30-day mortality in overall patient population was 66.6% (95% confidence interval, 64.7-68.4%), and pooled unadjusted risk ratio analysis confirmed that patients undergoing peripheral VA-ECMO had a lower in-hospital/30-day mortality than patients undergoing central cannulation (risk ratio, 0.92; 95% confidence interval, 0.87-0.98). Adjustments for important confounders did not alter our results.
CONCLUSIONS
In patients with postcardiotomy shock treated with VA-ECMO, central cannulation was associated with greater in-hospital mortality than peripheral cannulation.

Identifiants

pubmed: 31864699
pii: S0022-5223(19)32376-1
doi: 10.1016/j.jtcvs.2019.10.078
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1207-1216.e44

Investigateurs

Susan Dashey (S)
Hakeem Yusuff (H)
Richard Porter (R)
Caroline Sampson (C)
Chris Harvey (C)
Nicla Settembre (N)
Thomas Fux (T)
Gilles Amr (G)
Artur Lichtenberg (A)
Anders Jeppsson (A)
Marco Gabrielli (M)
Daniel Reichart (D)
Henryk Welp (H)
Sidney Chocron (S)
Mariafrancesca Fiorentino (M)
Andrea Lechiancole (A)
Ivan Netuka (I)
Dieter De Keyzer (D)
Maarten Strauven (M)
Kristiina Pälve (K)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Giovanni Mariscalco (G)

Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom. Electronic address: giovannimariscalco@yahoo.it.

Antonio Salsano (A)

Division of Cardiac Surgery, Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy.

Antonio Fiore (A)

Department of Cardiothoracic Surgery, Henri Mondor University Hospital, AP-HP, Paris-Est University, Créteil, France.

Magnus Dalén (M)

Department of Molecular Medicine and Surgery, Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Vito G Ruggieri (VG)

Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France.

Diyar Saeed (D)

Cardiovascular Surgery, University Hospital of Dusseldorf, Dusseldorf, Germany.

Kristján Jónsson (K)

Department of Cardiac Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Giuseppe Gatti (G)

Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy.

Svante Zipfel (S)

Hamburg University Heart Center, Hamburg, Germany.

Angelo M Dell'Aquila (AM)

Department of Cardiothoracic Surgery, Münster University Hospital, Münster, Germany.

Andrea Perrotti (A)

Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France.

Antonio Loforte (A)

Department of Cardiothoracic, Transplantation and Vascular Surgery, S. Orsola Hospital, University of Bologna, Bologna, Italy.

Ugolino Livi (U)

Cardiothoracic Department, University Hospital of Udine, Udine, Italy.

Marek Pol (M)

Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Cristiano Spadaccio (C)

Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom.

Matteo Pettinari (M)

Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburgl, Genk, Belgium.

Sigurdur Ragnarsson (S)

Department of Cardiothoracic Surgery, University of Lund, Lund, Sweden.

Khalid Alkhamees (K)

Prince Sultan Cardiac Center, Al Hassa, Saudi Arabia.

Zein El-Dean (Z)

Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom.

Karl Bounader (K)

Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France.

Fausto Biancari (F)

Heart Center, Turku University Hospital and University of Turku, Turku, Finland; Department of Surgery, University of Oulu, Oulu, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH